EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis

Tugba Toyran iD, Ertuğrul Bayram iD, Yasemin Aydınalp Camadan iD, Berksoy Sahin, Kubilay Dalcı, Yusuf Kemal Arslan iD, Melek Ergin

Medicina · 10.04.2026 · 62 (4) · 726

DOI: 10.3390/medicina62040726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, online erschienen am 10.04.2026. Verfasst von Tugba Toyran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey. Hauptthemen laut MEDLINE: B7-H1 Antigen, Breast Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Metaplastic breast carcinoma (MBC) is a rare, aggressive malignancy that is often resistant to conventional chemotherapy and characterized by a triple-negative phenotype. While immune checkpoint inhibition shows promise, the prognostic significance and distribution of programmed death-ligand 1 (PD-L1) expression within the heterogeneous architecture of MBC remain poorly understood. This study aimed to evaluate PD-L1 expression and the density of tumor-infiltrating lymphocytes (TILs) to clarify their roles in patient stratification and overall survival (OS). Materials and Methods: We retrospectively analyzed 48 MBC cases diagnosed between 2010 and 2025. PD-L1 expression was quantified using the Combined Positive Score (CPS) with the 22C3 antibody clone across diverse histological components. The density of stromal TIL density was assessed following internationally standardized guidelines. Clinical outcomes and clinicopathological parameters, including metastasis, lymphovascular invasion (LVI), and histological subtype, were correlated with biomarker status using Kaplan–Meier survival analysis and Cox proportional hazards regression models.

Results

PD-L1 positivity (CPS ≥1) was identified in 72.9% of cases, one of the highest rates documented in literature. Notably, an inverse relationship was observed with PD-L1-negative tumors, which exhibited significantly higher rates of distant metastasis (46.2% vs. 17.1%; p = 0.039). Multivariate analysis confirmed that low density of TILs (HR = 9.66; p = 0.016), metastasis (HR = 4.40; p = 0.023), and the presence of LVI (HR = 3.84; p = 0.047) were strong independent predictors of mortality. While PD-L1 status alone did not directly dictate overall survival, mean overall survival was markedly reduced in the low TILs cohort (32.2 months) compared to the high TILs group (114.2 months).

Conclusions

The high prevalence of PD-L1 expression supports routine screening for immunotherapy eligibility in MBC. Our findings suggest that PD-L1-negative cases represent a high-risk biological subset driven by alternative immune evasion mechanisms. Integrating TIL density with conventional pathological parameters provides a more robust prognostic framework, enabling personalized therapeutic strategies for this challenging malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenBreast NeoplasmsHumansFemaleRetrospective StudiesPrognosisMiddle AgedAgedLymphocytes, Tumor-InfiltratingAdultKaplan-Meier EstimateProportional Hazards ModelsBiomarkers, Tumor

Stichwörter der Autor:innen

PD-L1 expressioncombined positive scoreimmunotherapymetaplastic breast carcinomaprognosistriple-negative breast cancertumor-infiltrating lymphocytes

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
  • Department of Oncology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
  • Department of General Surgery, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
  • Department of Biostatistics, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.

ORCID-Profile: Tugba Toyran, Ertuğrul Bayram, Yasemin Aydınalp Camadan, Yusuf Kemal Arslan

Zitieren

APA

Toyran, T., Bayram, E., Aydınalp Camadan, Y., Sahin, B., Dalcı, K., Arslan, Y. K., & Ergin, M. (2026). The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis. Medicina, 62(4), 726. https://doi.org/10.3390/medicina62040726

Vancouver

Toyran T, Bayram E, Aydınalp Camadan Y, Sahin B, Dalcı K, Arslan YK, et al. The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis. Medicina. 2026;62(4):726. doi:10.3390/medicina62040726

BibTeX
@article{Toyran2026,
  author = {Toyran, Tugba and Bayram, Ertuğrul and Aydınalp Camadan, Yasemin and Sahin, Berksoy and Dalcı, Kubilay and Arslan, Yusuf Kemal and Ergin, Melek},
  title = {The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {4},
  pages = {726},
  doi = {10.3390/medicina62040726}
}
Kostenlos starten →